Oncolytics Biotech Inc ONCY

$0.63 -0.01 (-1.59%)

Valuation

Market cap
80,459,000
Revenue TTM
$0
Net income TTM
$-28,760,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
611,800
Avg volume
876,066
Day's range
$0.62 – $0.65
Shares out
127,511,000
Stochastic %K
6%
Beta
1.15
Analysts
Strong Sell
Price target
$4.42

Price

Company profile

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (“GI”) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply i...

Show more

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (“GI”) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
403 670 7377
Website
https://oncolyticsbiotech.com
Address
4350 Executive Drive, Suite 325, San Diego, United States

Latest news

Stocktwits

FoxM07 Oct 4, 7:34 PM 0 replies
FoxM07 Oct 4, 7:34 PM 0 replies
FoxM07 Oct 4, 7:34 PM 0 replies
FoxM07 Oct 4, 7:34 PM 0 replies
FoxM07 Oct 4, 7:34 PM 0 replies
Notable_Ex Oct 4, 5:59 PM
$ONCY In a regulatory ruling against Anson Funds, the SEC found that Anson Funds Managment navigated the cracks of the financial system by mischaracterizing trades and using intermediaries, such as those like the LYING ONCY BASHERS who keep appearing on all the ONCY message boards. https://www.sec.gov/files/litigation/admin/2024/ia-6622.pdf
1 replies
JohnnyC63 Oct 4, 5:36 PM
$ONCY Just look at the data, interim results - all results - to date, FDA responses to date. 11 years invested and still 100% behind the company.
1 replies
Notable_Ex Oct 4, 4:44 PM
$ONCY https://stockhouse.com/companies/bullboard?symbol=oncy
0 replies